Activity of BAL30072 alone or combined with -lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters | Zendy

Shazad Mushtaq | Zendy; Neil Woodford | Zendy; Russell Hope | Zendy; Rachael Adkin | Zendy; David M. Livermore | Zendy

Open Access

Activity of BAL30072 alone or combined with -lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters

Author(s) -

Shazad Mushtaq,

Neil Woodford,

Russell Hope,

Rachael Adkin,

David M. Livermore

Publication year - 2013

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt050

Subject(s) - meropenem , klebsiella pneumoniae , microbiology and biotechnology , enterobacteriaceae , acinetobacter baumannii , carbapenem , pseudomonas aeruginosa , agar dilution , biology , acinetobacter , efflux , antibiotics , escherichia coli , antibiotic resistance , bacteria , minimum inhibitory concentration , gene , biochemistry , genetics

We investigated the activity of BAL30072, a dihydroxypyridone monosulfactam, against carbapenem-resistant Enterobacteriaceae and non-fermenters (i) alone, (ii) combined with BAL29880 (to inhibit AmpC) and/or clavulanate [to inhibit extended-spectrum β-lactamases (ESBLs)] and (iii) combined 1:1 with meropenem.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research